GlassScriptPhysician profile
Ashley E Myers
NPI 1881035871
$2,029.28
in general payments reported to CMS, 2019-2025
22 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $514 · 2023: $362 · 2024: $394 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $793.76 | 2021-2025 | Trelegy Ellipta, Pediarix, Bexsero |
| Lilly USA, LLC | $184.02 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $150.18 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.60 | 2024-2025 | Caplyta |
| Astellas Pharma US INC | $90.71 | 2021-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.02 | 2021-2022 | |
| Amgen INC. | $79.11 | 2021-2024 | Otezla, Repatha |
| Novo Nordisk INC | $73.86 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $60.70 | 2022 | |
| Medtronic, INC. | $52.45 | 2021-2022 | |
| Dexcom, INC. | $45.50 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $43.86 | 2021-2024 | |
| Dynavax Technologies Corporation | $36.70 | 2024-2025 | Heplisav-B |
| Astrazeneca Pharmaceuticals LP | $33.94 | 2023-2025 | Airsupra, Farxiga |
| Boston Scientific Corporation | $33.42 | 2025 | Wavewriter Alpha Prime 16 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $32.44 | 2024 | Auvelity |
| Sunovion Pharmaceuticals INC. | $25.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.67 | 2021-2022 | |
| Philips North America LLC | $20.10 | 2024 | (Ck7) Extended Holter |
| Merck Sharp & Dohme LLC | $15.13 | 2021 | |
| Exact Sciences Corporation | $14.65 | 2023 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.